Podcasts about cgms

Feeling tired, craving sugar, or struggling to focus? You're not alone — 88% of Americans have poor metabolic health, and most don't even realize it. In this episode of Get Well Better by The Lanby, Registered Dietitian and Wellness Advisor Taylor Fazio breaks down why blood sugar balance is the foundation of health — and how small daily habits can create massive changes in your energy, hormones, sleep, and longevity.Learn what metabolic health really means, how continuous glucose monitors (CGMs) give you real-time insight into your body, and why stabilizing your blood sugar may be the most powerful thing you can do for your overall well-being.Taylor also shares practical tips you can start using today — like how the order of your meals can reduce glucose spikes by 70%, why a 10-minute walk after eating is pure magic, and how sleep and stress affect your metabolism as much as food.Plus, get a sneak peek at The Lanby's upcoming CGM Masterclass — a 4-week guided program designed to help you personalize your nutrition, movement, sleep, and stress using your own glucose data.Learn more or sign up for The Lanby CGM Masterclass: https://www.thelanby.com/metabolic-healthSubscribe to Get Well Better by The Lanby: Apple Podcasts: https://podcasts.apple.com/us/podcast/get-well-better Spotify: https://open.spotify.com/show/get-well-betterYouTube: @TheLanby Or search “Get Well Better by The Lanby” on your favorite podcast platform!VISIT THE LANBY: Explore membership and learn more about The Lanby's functional medicine approach:https://www.thelanby.comFOLLOW THE LANBY ON SOCIAL: Instagram: https://www.instagram.com/thelanby Tiktok: https://www.tiktok.com/@thelanby LinkedIn: https://www.linkedin.com/company/thelanbySTAY IN THE KNOW: Subscribe to The Lanby newsletter for health tips, podcast drops, and expert insights: https://www.thelanby.com/newsletter

Gene therapy isn't science fiction anymore, it's becoming one of the most exciting frontiers in diabetes care. In this episode, Dr. Jeremy Pettus and Dr. Steve Edelman sit down with Dr. Fraser Wright, career gene therapist and Co-Founder/Chief Gene Therapy Officer at Kriya Therapeutics, to explore how gene therapy could one day help the body make its own insulin.Together, they unpack what gene therapy actually is, Dr. P's involvement as a medical consultant for Kriya Therapeutics, how AAV (adeno-associated virus) vectors work, and what makes this “one-and-done” approach so different from traditional treatments. From success stories in blindness and hemophilia to emerging type 1 diabetes studies, the trio breaks down the science, the safety, and the hope behind this revolutionary research.You'll learn how gene therapy has moved from rare diseases to more common ones, why the first human trials in diabetes are on the horizon, and what and what this could mean for long-term blood sugar control and independence from injections.Key Topics:Gene Therapy 101: How gene therapy differs from protein-based drugs like insulin, and why AAV vectors act as safe, engineered delivery vehicles rather than infectious viruses.Why AAV, Why Now: Seven FDA-approved AAV-based therapies have proven the potential of long-term, single-dose treatments.From Eyes to Endocrine: Lessons learned from retinal gene therapy are now guiding approaches to metabolic conditions like diabetes.The Type 1 Diabetes Approach: A muscle-targeted program aims to help the body naturally produce insulin and stabilize blood sugar levels.Control and Safety: Built-in glucose sensing and the ability to turn off gene expression ensure precision and reversibility.Real-World Considerations: How exercise, treatment site, and existing technologies like pumps or CGMs could work alongside this therapy.0:00 – Intro: Jeremy and Steve introduce gene therapy and why this topic is a game-changer2:15 – What gene therapy is and how it's different from standard protein-based treatments4:54 – Understanding AAV: safety, engineering, and why it's the preferred delivery method8:50 – Real-world success: seven FDA-approved AAV therapies for genetic diseases12:20 – Lessons learned from treating blindness and how they apply to diabetes17:40 – The Type 1 Diabetes model: using muscle tissue to produce insulin22:15 – Managing control, glucose sensing, and preventing hypoglycemia25:50 – Safety measures and how treatment can be reversed locally if needed28:30 – Exercise, durability, and what animal studies reveal about real-life performance31:10 – Timelines, trials, and what's next for gene therapy in diabetes. What's Ahead: Clinical trials expected to begin around 2026, offering cautious but real optimism for the future of diabetes treatment.Visit TCOYD's Website for more diabetes edutainment for people living with diabetes: tcoyd.org**Tune in for two new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!**Follow our social media channels to empower yourself with the essential areas of diabetes knowledge led by two endocrinologists living with type 1 diabetes: Facebook  |  Instagram  |  YouTube ★ Support this podcast ★

Save 20% on all Nuzest Products WORLDWIDE with the code MIKKIPEDIA at www.nuzest.co.nz, www.nuzest.com.au or www.nuzest.comCurranz Supplement: Use code MIKKIPEDIA to get 20% off your first order - go to www.curranz.co.nz  or www.curranz.co.uk to order yours  In this episode, Mikki speaks with Professor Michael Snyder, Chair of Genetics at Stanford University and a global leader in personalised medicine. They explore how our genes, gut microbiome, and lifestyle choices interact to shape metabolic health—and why we all respond so differently to the same foods. Mike shares insights from his groundbreaking research using wearables and genomics to track health in real time, the future of personalised nutrition, and how continuous glucose monitors (CGMs) can help anyone understand their body better. They also discuss the link between viral infections and diabetes, why strength training matters more than you think, and how food truly functions as medicine.Highlights:The genetics of metabolic individuality and why “one-size-fits-all” diets don't workHow CGMs reveal surprising glucose spikes and help improve long-term healthThe microbiome's crucial role in metabolism and disease riskSubtypes of diabetes and what they mean for treatment and lifestyleWhy Professor Snyder believes health tracking is the future of preventive medicine Contact Mikki:https://mikkiwilliden.com/https://www.facebook.com/mikkiwillidennutritionhttps://www.instagram.com/mikkiwilliden/https://linktr.ee/mikkiwilliden

If you want to improve your energy and long-term health, start by understanding how your body uses glucose.In this episode of A Whole New Level, Dr. Benjamin Bikman, scientist and author of Why We Get Sick, joins Mike Haney to unpack the science of glucose metabolism and insulin resistance—and why blood sugar isn't the whole story.Dr. Bikman explains how insulin regulates energy balance, why HbA1c is only part of the picture, and how chronic high insulin can silently drive weight gain, fatigue, and metabolic disease. He also shares practical ways to lower insulin naturally through diet, exercise, and daily habits.They discuss:Why insulin, not glucose, is the root of metabolic dysfunctionWhat HbA1c and fasting glucose really tell youThe early signs of insulin resistance most people missHow muscle tissue protects against high glucose and insulinWhy low-carb and intermittent fasting aren't one-size-fits-allPractical nutrition and movement strategies for better metabolic flexibilitySign Up to Get Your Free Ultimate Guide to Glucose: https://levels.link/wnl

In this episode, host Lindsey Elizabeth Cortes, a sports dietitian and entrepreneur, delves into the world of female athlete nutrition with guest Nick Padula, a private practice sports dietitian and professor at the University of Southern California. They discuss the importance of personalized nutrition, the impact of dietary choices on performance, and the power of comprehensive testing, including continuous glucose monitors (CGMs), genomics, and microbiome analysis.   Nick shares his experiences working with various athletes, from boxers to endurance runners, and underscores how detailed nutrition data can significantly enhance training and recovery. Lindsey and Nick also explore practical approaches to fueling for both everyday athletes and elite sports performers, emphasizing the difference between generalized guidelines and individualized nutritional insights.   Episode Highlights: 01:24 Meet Nick Padula: Sports Dietician Extraordinaire 02:50 The Intersection of Clinical and Sports Nutrition 04:14 The Science and Ethics of Weight Cutting 09:52 Customizing Nutrition Through Testing 17:06 Understanding Genomic and Microbiome Testing 26:26 Addressing RED-S and Support Options 29:13 Understanding Gluten Intolerance 32:28 The Role of Continuous Glucose Monitors (CGMs) 35:37 Practical Applications of CGMs 42:05 The Importance of Recovery Nutrition 45:30 Exploring Nutrition Packages and Testing 47:07 The Impact of Environmental Toxins 53:31 Fun Questions and Final Thoughts Nick Padula has been a practicing Dietitian since 2015 as a clinical dietitian, a foodservice director. In addition to You Trition, LBC Nutrition, a dietetic consultant company, is a lecturer and coordinator with the University of Southern California Master’s in Nutrition program and Sports Dietitian for Cypress Junior College Athletics. ⁠   Nick studied nutrition and dietetics at Long Beach State University and received a Bachelor's degree in 2012 and Master's degree in Nutrition and Dietetics with a concentration in Sports Nutrition from Texas Tech University. ⁠In his practice he has worked with triathletes, professional boxers, endurance runners, professional soccer players, high school athletes, and the USC football and basketball teams. Nick is an avid runner, weightlifter, and golfer.   Connect with Nick: www.youtritionscience.com IG:@Youtrition_science Email: nick@youtritionscience.com   Resources and Links: For more information about the show, head to work with Lindsey on improving your nutrition, head to: http://www.lindseycortes.com/ Join REDS Recovery Membership: http://www.lindseycortes.com/reds WaveBye Supplements – Menstrual cycle support code LindseyCortes for 15% off: http://wavebye.co Previnex Supplements – Joint Health Plus, Muscle Health Plus, plant-based protein, probiotics, and more; code riseup for 15% off: previnex.com Female Athlete Nutrition Podcast Archive & Search Tool – Search by sport, condition, or topic: lindseycortes.com/podcast Female Athlete Nutrition Community – YouTube, Instagram @‌femaleathletenutrition, and private Facebook group

In this episode, Tina sits down with fellow FDN practitioner Michele Scarlet for an honest conversation about women's health, metabolism, and weight loss. Michele shares her personal story with breast implant illness and how the hidden toxic load on her body impacted her health. They discuss why “healthy habits” like 4 a.m. workouts, fasted training, and constant discipline and willpower can sometimes do more harm than good, and why the “calories in, calories out” approach fails without strong metabolic health. The conversation also dives into the real causes of bloating, the crucial role your liver plays in energy and fat loss, and how to naturally support it for better hormone balance. Michele helps clear up confusion around carbs, belly fat, and CGMs while offering practical strategies to help women achieve true, sustainable health. Here's what you'll learn: - Her personal story with breast implant illness and the hidden toxic load on her body - Why your 4 a.m. workouts, fasted training, and pushing harder could be stalling your progress - Why willpower and discipline aren't the answer and what you should do instead - Why calories in, calories out fails without strong metabolic health - What constant bloating really means and how to fix it - The overlooked role your liver plays in weight loss and metabolism - How to naturally support your liver for better energy and fat loss - Clearing up confusion around carbs, belly fat, and CGMs Explore microdosing and other peptides: https://elliemd.com/tinahaupert Peptides for Women: https://carrotsncake.com/offers/3Q7wttmr?coupon_code=PROTOCOL19 Connect with Tina Haupert: https://carrotsncake.com/ Facebook: Carrots 'N' Cake https://www.facebook.com/carrotsncake Instagram: @carrotsncake https://www.instagram.com/carrotsncake YouTube: Tina Haupert https://www.youtube.com/user/carrotsncake About Tina Haupert: Tina Haupert is the owner of Carrots ‘N' Cake as well as a Certified Nutrition Coach and Functional Diagnostic Nutrition Practitioner (FDN-P). Tina and her team use functional testing and a personalized approach to nutrition to help women find balance within their diets while achieving their body composition goals. Connect with Michele Scarlet: https://www.michelescarlet.com/ IG: https://www.instagram.com/michelescarlet_ Youtube: https://www.youtube.com/@michelescarlet_/videos About Michele Scarlet: I've spent over 15 years helping women feel strong, confident, and in control of their health. But it wasn't until I faced my own struggles with fatigue, hormone imbalances, and weight loss resistance that I realized true health goes far deeper than diet and exercise. That's when I turned to functional lab testing and a whole-body approach—and it changed everything. Now, I help women uncover the root cause behind their low energy, hormonal imbalance and their weight loss struggles to achieve lasting results, all while reclaiming the motivation and vitailty they thought they'd lost forever. As a Board-Certified Functional Medicine Practitioner, Functional Diagnostic Nutrition Practitioner, Certified Personal Trainer, and Women's Health Coach, I bring science, strategy, and compassion to every woman I work with.

Alzheimer's and dementia aren't just a matter of age or genetics. Increasing evidence shows that metabolic health—particularly insulin resistance—plays a key role in cognitive decline.In this episode of A Whole New Level, neurologist and bestselling author Dr. David Perlmutter joins Mike Haney to explore the links between brain health and metabolism. They discuss the role of insulin resistance and inflammation in Alzheimer's disease, the biomarkers that can reveal risk decades before symptoms, and how lifestyle interventions can dramatically change your trajectory.Topics include:Key biomarkers for assessing brain health: fasting insulin, A1C, homocysteineWhy targeting inflammation may matter more than targeting amyloid plaquesThe promise and limitations of GLP-1 medications for dementia and Parkinson'sPractical steps you can take now to protect long-term cognitive functionSign Up to Get Your Free Ultimate Guide to Glucose: https://levels.link/wnl

In this episode of The Lisa Fischer Said Podcast, Lisa sits down with Kara Collier, registered dietitian and co-founder of Nutrisense, to unpack the truth about metabolic health, insulin resistance, and how continuous glucose monitors (CGMs) are transforming the way we understand our bodies. Kara shares why she left traditional healthcare, the shocking flaws in hospital nutrition, and how real-time data from CGMs empowers behavior change. Whether you're keto, carnivore, plant-based, or just curious, this episode reveals why everyone should wear a CGM at least once. Learn how glucose, insulin, fasting, aging, and hormones all play into the metabolic puzzle—and how Nutrisense is helping thousands take control of their health.     WEBSITE: https://www.karacollier.com/courses/GlucoseAcademy     Nutrisense Page with 33% Discount: https://www.nutrisense.io/marketing/kara-collier     INSTAGRAM: https://www.instagram.com/karacollierrd/     INSTAGRAM:  https://www.instagram.com/nutrisenseio/     FACEBOOK: https://www.facebook.com/nutrisenseio     EPISODE SPONSOR:  https://www.davidsburgers.com/     EPISODE SPONSOR:  https://marlsgate.com     LISA'S LINKS:     Lisa Fischer Said Academy:  https://lisafischersaid.com/academy/     Website:  lisafischersaid.com     For more information on group intermittent fasting  coaching with Lisa, email fasting@lisafischersaid.com     For more information on one-on-one or group health coaching with Lisa, email healthcoaching@lisafischersaid.com     Podcast produced by clantoncreative.com    

In this episode of the HealthspanMD Podcast, Dr. Robert Todd Hurst, MD, FACC, FASE sits down with Patty and Rick Rife to unpack their powerful journey through proactive, personalized care. After years of strict vegan eating, they were shocked to discover early signs of heart disease, prediabetes, and rising blood pressure. What followed was a complete transformation driven by advanced testing, continuous glucose monitoring, and a tailored plan that actually worked for their bodies.   In this episode of the HealthspanMD Podcast, Dr. Robert Todd Hurst, MD, FACC, FASE sits down with Patty and Rick Rife to unpack their powerful journey through proactive, personalized care. After years of strict vegan eating, they were shocked to discover early signs of heart disease, prediabetes, and rising blood pressure. What followed was a complete transformation driven by advanced testing, continuous glucose monitoring, and a tailored plan that actually worked for their bodies.   They share how switching to a low-carb, high-protein diet led to dramatic improvements in energy, labs, and overall health, and why health is always a team effort. Whether you're feeling stuck with your current plan or wondering if your numbers tell the whole story, this episode is a must-listen.   Patty and Rick Rife are a health-conscious couple who came to HealthspanMD looking for clarity, not just checkups. After four years on a strict plant-based diet, Rick's elevated calcium score, insulin resistance, and surprising lab results sparked a major shift. Under the guidance of Dr. Robert Todd Hurst, MD, FACC, FASE, they adopted a more personalized, results-driven approach and reversed their risk trajectory in weeks.    Key Timestamps 00:00 – Meet Patty and Rick Rife + why they came to HealthspanMD 02:00 – Going vegan for heart health: expectations vs reality 04:30 – Early signs of arterial plaque and metabolic dysfunction 06:00 – When “healthy” isn't enough: lab results that shocked them 08:15 – From vegan to low-carb: making the dietary pivot 11:00 – Dramatic changes in A1C, triglycerides, and insulin in 5 weeks 13:45 – The power of CGMs for personalized feedback 15:30 – “Healthy” foods that spiked blood sugar, and what didn't 18:30 – How food order, stress, and walking affect glucose response 21:00 – Why one diet does not fit all 24:00 – Repatha, medication strategy, and reversing artery disease 27:00 – Mindset shifts, confidence, and redefining health together 30:00 – Health as a team sport and what's next for the Rifes This information is for educational purposes only and is not medical advice. Don't make any decisions about your medical treatment without first talking to your doctor. *Connect* *with* *HealthspanMD* :

Send us a textHarvard-trained physician-scientist Dr. Nick Norwitz joins me to unpack the real drivers of metabolic health. He shares how keto sent his severe ulcerative colitis into remission within one week, why “calories in, calories out” is a dead-end tautology, what happened when he overfed ~6,000 calories/day and didn't gain weight, and how medical training ignores nutrition while Big Food-friendly myths persist. We hit CGMs in med-ed, GLP-1s, statins' surprising effects on GLP-1, funding unbiased metabolic research, and whether long-term keto is not just therapeutic but optimal.Where To Find Nick Norwitz:Youtube:  @nicknorwitzMDPhD  Website: https://www.nicknorwitz.com/Instagram: https://www.instagram.com/nicknorwitz/X: https://x.com/nicknorwitz

Type 2 diabetes is one of the most common chronic conditions in the U.S., but it doesn't have to define or limit your life. In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus—two endocrinologists with decades of experience—break down practical strategies for living well with type 2. From the latest medications and tools to everyday lifestyle choices, they highlight what really makes a difference in the long run. Their goal? To show you that type 2 diabetes is not only manageable but that taking control can actually improve your health and quality of life.Get Educated About What's Happening in Your Body: Understanding insulin resistance, metabolic syndrome, and why type 2 diabetes is more than just “high blood sugar.”Know Your Numbers: The key benchmarks for A1c, blood sugar, cholesterol, and blood pressure—and why even small improvements matter.Build the Right Care Team: How to find and work with providers who can guide you through treatment options and keep you on track.Food and Drink That Work for You: Why portion control, balance, and smart substitutions matter more than strict diets or deprivation.Move Your Body (Without Overthinking Exercise): How realistic activity goals—walking, stretching, or even gardening—can improve insulin sensitivity and overall health.The Medications Changing the Game: Why GLP-1s, SGLT2 inhibitors, and CGMs are considered life-changing tools in type 2 diabetes care—and what you should know about them.And That's Just the Start…: From mental health to long-term complication prevention, there are even more strategies in this episode to help you thrive with type 2 diabetes. ★ Support this podcast ★

Longevity is a hot health topic, but what factors move the needle on not only how long you live but how long you experience relatively good health? Some lab and other tests can help assess how healthy you're aging and provide context for what lifestyle and other changes to make. Dr. Matt Kaeberlein and Mike Haney discuss the tests that help assess healthy aging, how mental health and physical health are intricately connected, which lifestyle factors might expand your health span, and where the research stands on various longevity topics.Get a Free Guide to Understanding Your Lab Results: https://levels.link/wnl

Text us a comment or question!Ever wonder why some foods leave you energized and satisfied while others knock you into a mid-afternoon crash - or make fat loss feel impossible? The answer lies in your blood sugar. And today, we're breaking down how you can finally take control of it. In this episode, I sit down with Kara Collier, co-founder and VP of Health at Nutrisense, to uncover how continuous glucose monitoring (CGMs) and smart lifestyle strategies can help you outsmart stubborn fat, reclaim your energy, and build the lean, strong body you deserve in your 50s, 60s, and beyond. Kara is a Registered Dietitian and one of the leading voices in metabolic health. She's helped over 150,000 people use real-time data and practical tools to create sustainable change - and today, she's sharing those insights with you. What you'll learn in this episode:Why blood sugar spikes and crashes sabotage fat loss, energy, and cravingsThe surprising individuality of how foods affect your glucose (bananas might not be the villain after all!)Simple hacks to keep blood sugar balanced - without giving up your favorite foodsHow stress, sleep, and even the time of day can dramatically impact your glucose responseWhy building muscle is one of the most powerful tools for metabolic healthSupplements and “biohacks” that actually move the needle (and which ones are just pebbles, not boulders) Whether you're struggling with stubborn belly fat, daily energy crashes, or just want to feel younger and more vibrant, this conversation will show you how to finally master The Glucose Game. 

Hypoglycemia (low blood sugar) can be more dangerous than hyperglycemia (high blood sugar), especially because it can lead to immediate and life-threatening situations. While high sugar levels over time can damage organs and increase the risk of complications, a sudden drop in glucose can impair brain function, cause unconsciousness, seizures, stroke and even be fatal if not treated promptly. This is where Continuous Glucose Monitoring (CGM) systems have become a game-changer. Although traditional glucometers are still widely used, especially by individuals who take insulin three to four times a day, CGMs offer a more convenient and accurate option. Many people on insulin therapy are advised to check their blood sugar at least three times daily — which isn't always easy. CGMs solve this by offering real-time tracking and alerts via your smartphone. Worn on the arm or abdomen, CGMs can be programmed to alert you when your glucose levels begin to drop. For instance, if you set an alert at 90 mg/dL, the device might warn you at 88 mg/dL, giving you enough time to take action. This is especially beneficial for those with hypoglycemia unawareness, where symptoms are no longer felt even at dangerously low levels. It is also important to know that if someone has one episode of hypoglycemia, his risk of developing 2nd episode of hypo is higher and during this 2nd / 3rd hypo, the threshold for symptoms of recognition may go further low, this is known as Hypoglycemia-Associated Autonomic Failure (HAAF), can worsen with repeated episodes. Thus, we should avoid recurrent hypoglycemia episodes. To stay safe, especially for those new to diabetes care, never go more than 3.5 to 4 hours without eating. Even if you're not hungry, regular small meals are essential. Prioritize your health — and don't hesitate to communicate your needs at work or school. Expert - Dr. Sunil Gupta Anchor – Ms. Kalyani Gokhale Recorded on: 28/03/2025 Recorded at: Akashwani Nagpur

Amelia Wood is an ACE-certified Personal Trainer dedicated to helping people feel strong, confident, and capable in their own bodies. Known for her approachable, no-gimmicks style, Amelia focuses on building sustainable fitness habits that fit real life. She's passionate about functional strength, movement that feels good, and empowering others to discover just how resilient they can be. In this episode, Dr. Brian, Dr. Tro, and Amelia talk about… (00:00) Intro (04:04) Why Amelia started her podcast, The Magic of Metabolic Health, and became a personal trainer (13:42) Learning delayed gratification and sustainably healthy living (18:06) Learning to enjoy exercise (25:04) Looking for the ‘why' behind behaviors you want to change (30:56) The five stages of achieving success (35:18) Cultural considerations when building a sustainably healthy lifestyle (47:39) Merging acting, entertainment, and wellness (51:24) What it means to be a ‘food first' personal trainer (and why CGMs are awesome!) (01:06:53) Gut health and overall metabolic health (01:11:50) A1C, fat, and butyrate (01:18:32) Outro For more information, please see the links below. Thank you for listening!   Links:   Please consider supporting us on Patreon: https://www.lowcarbmd.com/   Resources Mentioned in this Episode: Food Addiction Reset: https://www.foodaddictionreset.com Nutrition Network: https://nutrition-network.org Tro on Amelia's Podcast: https://www.youtube.com/watch?v=hQQkpHmwIdE   Amelia Wood: IG: https://www.instagram.com/primitivepulsefitness/ Website: https://www.primitivepulsefitness.com Podcast: https://www.youtube.com/@themagicofmetabolichealth The Great Surprisal: https://www.instagram.com/thegreatsurprisal/?hl=en   Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author   Dr. Tro Kalayjian:  Website: https://www.doctortro.com/ Twitter: https://twitter.com/DoctorTro IG: https://www.instagram.com/doctortro/   Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.    Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://doctortro.com/community/ 

This week on We Are T1D, Mike and Jack tackle the ins and outs of Continuous Glucose Monitors (CGMs) — those little gadgets that keep an eye on your sugars around the clock, often with a bit of drama thrown in for good measure. From the beeping alerts that can wake you at 3 AM to the occasional sensor mishap, they explore how these devices can be both lifesavers and sources of anxiety.Join the duo as they delve into the specifics of CGMs, including their functionality, the different types available in the UK, and why trend arrows are a game changer. They share personal anecdotes, laugh at the chaos that comes with using CGMs, and even take a peek at some hilarious Reddit stories about sensor mishaps.What to Expect:The basics of how CGMs work and why they're essential for Type 1 diabeticsThe difference between the Dexcom and Libre systemsReal-life tales of sensor struggles and triumphsTips for keeping your CGM stuck on, even through showersFuture tech: What could CGMs look like in the coming years?“Without CGMs, diabetes would be 100 times harder.” – MikeConnect with Us:Email: wearet1dpodcast@gmail.comWebsite: www.wearet1d.comInstagram: @t1d_mike & @t1d_jackWhatsApp Community: Join hereExtra Resource:Diabetes UK – Continuous Glucose MonitoringHashtags:#Type1Diabetes #T1DLife #DiabetesPodcast #WeAreT1D #T1DCommunity #CGM #DiabetesTech

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, I sit down with Jenna Smith, who was diagnosed with Type 1 Diabetes at the age of 26. Jenna shares her powerful story of living with T1D for nearly two decades, navigating the challenges of motherhood, divorce, intimacy, and dating, while also facing a breast cancer diagnosis in 2023.Jenna's openness about the emotional and physical toll of managing both T1D and cancer highlights the importance of resilience, community, and giving ourselves grace. From her early resistance to diabetes technology, to finding the courage to embrace diabetes tools Jenna's perspective offers hope and relatability for anyone living with this condition.This conversation dives into the real, messy, and inspiring realities of diabetes management—and the strength it takes to keep moving forward.

Today I'm sitting down with Dr. Filip Larsen, the physiologist behind a tiny green shot that pros say helps them go harder with less burn. One preprint shows lower blood lactate at the same power after a single dose; WorldTour riders like Mads Pedersen claim they feel a real boost. But is it biology or placebo? We'll unpack the science, design a blinded test I can do on the bike, and then go way beyond the drink: overtraining, CGMs, mitochondria, and how to actually train smarter. NOMIO is clinically proven to:Lower lactate levels, Reduce oxidative stress, Improve training adaptations And deliver a noticeable boost from the very first dose. Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.drinknomio.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and check out this game changing supplement. 4iiiiReady to elevate your cycling game? Trust the 4iiii PRECISION 3+ Powermeter—precision, performance, and peace of mind, all in one.Learn more by visiting http://www.4iiii.comSHOPIFY Turn your big business idea into reality with Shopify on your side. Sign up for your one-dollar-per-month trial and start selling today at www.shopify.co.ukLlyods By partnering with British Cycling, Lloyds is helping more people experience the joyof riding and showing how those small personal pedal strokes can move us all forward.So if you haven't already, maybe now is the time to get on a bike yourself. Lloyds, thereat every stage.EXPOSURE LIGHTS Level up your night rides—check out the updated Exposure Lights bar range today at www.exposurelights.com If you're in North America and run a shop, pre-orders are open now; everyone else, hit your local bike store or Exposure online and tell them Roadman sent you.LLYODSBy partnering with British Cycling, Lloyds is helping more people experience the joy of riding, and showing how those small personal pedal strokes can move us all forward.

Living with type 1 diabetes is a daily grind, full of numbers, decisions, and constant adjustments, but it doesn't have to feel overwhelming. In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus two endocrinologists who also live with T1D, share their top 10 tips for making life with diabetes more manageable and a little easier to navigate. They cover everything from setting realistic blood sugar goals and understanding the metrics that matter most, to smart supply hacks that can save you stress when you least expect it. They also dive into why celebrating the small wins like getting through the night without a low or nailing your pre-meal insulin timing can make a big difference in your long-term mindset. Whether you're newly diagnosed or decades into the journey, this episode is packed with advice you can use today and into the future.Key Topics:Perfection Isn't the Goal: Why aiming for progress—and not flawless numbers—keeps you healthier and less stressed.Know the Benchmarks That Matter: A1C, time in range, and minimizing hypoglycemia are key to long-term health.Celebrate the Small Wins: Even the little victories count, and they help build momentum in the day-to-day grind.Be Prepared With Backups: Why extra insulin, CGMs, and supplies are non-negotiable.Don't Forget the “Non-Blood Sugar Stuff”: Eye exams, blood pressure, and cholesterol deserve just as much attention.And There's More… From food strategies to mental health hacks, this episode is packed with practical advice you won't want to miss—tune in for all 10 tips!Visit TCOYD's Website for more diabetes edutainment for people living with diabetes: tcoyd.org**Tune in for two new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!**Follow our social media channels to empower yourself with the essential areas of diabetes knowledge led by two endocrinologists living with type 1 diabetes: Facebook  |  Instagram  |  YouTube ★ Support this podcast ★

Your thyroid test results explained: The thyroid is a butterfly-shaped gland in your neck that affects many facets of health. When it doesn't function optimally, symptoms can ensue. That's where testing comes in, but the results can be tricky to interpret (and treat if necessary) without a knowledgeable clinician. Dr. Angela Mazza and Mike Haney discuss thyroid function, thyroid hormone and related tests and what they mean, treatment for thyroid conditions, the benefits of an integrative approach to thyroid care, and more.Get a Free Guide to Understanding Your Lab Results: https://levels.link/wnl

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this inspiring episode, I sit down with twin sisters Lisa and Lindsay Rusch, both living with type 1 diabetes, alongside their older brother who also has T1D. Beyond their personal diabetes journeys, the sisters are co-owners of Brekkie Shack, a health-focused restaurant in Columbus, Ohio. This episode is packed with wisdom, entrepreneurial spirit, and practical tips for anyone managing diabetes—or supporting someone who is.

Hi friends! I have a brand new episode live, and today I'm diving into a powerful conversation with Kara from NutriSense all about metabolic health, continuous glucose monitoring, and the role of human connection in building sustainable lifestyle changes. I'm SO excited for you to listen to it!! Here's what we chat about: Why metabolic health is the foundation for your energy, focus, and long-term wellness The most common dietary mistakes that spike blood sugar (and how to avoid them) How continuous glucose monitors (CGMs) can give you real-time insights into your body The importance of stress management and its impact on blood sugar regulation Why AI can support—but never replace—the empathy of human coaching Practical strategies for creating small, sustainable healthy habits that actually stick This episode is packed with insight and encouragement to help you take control of your metabolic health and feel your best every day. Kara Collier is the co-founder and VP of Health at Nutrisense, one of the fastest-growing health tech startups in the U.S. She's reshaping how we approach prevention, behavior change, and metabolic health. A Registered Dietitian Nutritionist and Certified Nutrition Support Clinician, Kara has helped over 150,000 people improve their health by combining real-time data, like continuous glucose monitoring, with personalized coaching and practical lifestyle strategies. She's a passionate advocate for how technology and human support can drive sustainable health change. Kara is a Forbes 30 Under 30 honoree and has been recognized with HLTH's "Food as Medicine" award. Her work has been featured by Forbes, UC Berkeley, and Medcitynews and she is a frequent speaker at health conferences and podcasts. When she's not talking about health and data, Kara is usually exploring the mountains, playing volleyball, or lifting heavy things. Make sure you're subscribed to my newsletter For my free Autoimmune Healing ebook, click here. Detailed show notes here: https://fitnessista.com/podcast Partners: Check out We Feed Raw! Maisey goes crazy for this! I use it as a topper for her kibble or mix it into her pup loaf. You can try the raw version, the raw dehydrated kibble, and they'll help you customize a plan for your pup. Use FITNESSISTA40 for 40% off your Meal Plan Starter Box here!  Check out my new favorite red light device here, and use the code FITNESSISTA for a huge discount.  I've been using Nutrisense on and off for a couple of years now. I love being able to see how my blood sugar responds to my diet and habits, and run experiments. You can try out Nutrisense here and use GINA30 for 30% off.  If any of my fellow health professional friends are looking for another way to help their clients, I highly recommend IHP. You can also use this information to heal yourself and then go one to heal others, which I think is a beautiful mission. You can absolutely join if you don't currently work in the health or fitness industry; many IHPs don't begin on this path. They're friends who are passionate to learn more about health and wellness, and want to share this information with those they love. You can do this as a passion, or start an entirely new career. You can use my referral link here and the code FITNESSISTA for up to $250 off the Integrative Health Practitioner program. I highly recommend it!   Thank you so much for listening and for all of your support with the podcast! Please be sure to subscribe, and leave a rating or review if you enjoyed this episode. If you leave a rating, head to this page and you'll get a little “thank you” gift from me to you. http://fitnessista.com/podcastreview

His personal journey started as a retail pharmacist just trying to help diabetic patients. What he learned over the last decade is that teaching patients about the impact of diet, medications and lifestyle is the most valuable tool for improving health outcomes.He wanted to use his background as a pharmacist to fill that need for patient education. Unlike pharmacy school, he now has evidence-based information at his fingertips. And for the curious-minded, there are several clever ways to discover where conflicts of interest in the government, food, and pharmaceutical industries have shaped our misunderstanding of chronic disease. ​On a personal level, he found the ketogenic diet to be a powerful tool in helping him drop over fifty pounds and fuel his newly found passion for the watersport, SUP (stand-up paddle). He was able to achieve this goal and significantly improve various health markers. This personal dietary experiment added passion to his career transition from a traditional retail pharmacist to an educator and coach. Before he knew it, he was offering diabetes classes and leading a weekly support group. ​With recent advances in wearable technologies like CGMs (continuous glucose monitoring) and smart watches, patients can get important feedback in real-time regarding the consequences of their choices. His role is to facilitate learning as they navigate their own personal trek back to better health. https://www.unscriptedpharmacist.com/http://www.yourlotandparcel.org

Greater accessibility to glucose biosensors has led to their use to improve metabolic health, prevent disease, and feel better. Historically, these biosensors for monitoring glucose were only available with a prescription, often reserved for people with diabetes, but now with brands like Stelo, they are available over the counter. Dom D'Agostino, PhD, and Ben Grynol discuss how biosensors can be a tool for anyone to improve overall health, reduce risk for chronic diseases, manage women's health including menstrual cycles and the menopause transition, help with fueling strategies for workouts and performance, prevent energy crashes, and more.Sign Up to Get Your Free Ultimate Guide to Glucose: https://levels.link/wnl

This is a story of faith, community, healing, and self-advocacy. Twenty years ago Amy Faith Folger discovered the keto diet. After reading Jason Fung's book on intermittent fasting she lost 85 pounds in 3 MONTHS! Thanks to her community, her faith, and her relentless pursuit of weight-loss strategies that work, she has been able, so far, to drop 160 pounds.   In this episode, Dr. Brian, Dr. Tro, Amy, and Adele talk about… (00:00) Intro (08:47) Losing weight on carnivore with lipodemiao (15:08) What NOT to do if you are a doctor trying to help a patient with lipodemiao and obesity (24:30) CGMs and stress (26:47) Taking care of yourself for the sake of the people in your life (35:05) Atrial fibrillation, obesity, and electrolyte deficiency (42:53) Insufficient education of patients on nutrition and the addiction component of  (45:00) Covid mRNA vaccine injury and death (51:39) The power of community and taking care of your gut biome (56:54) Why we need to teach people HOW to cook keto/carnivore meals (58:34) GLP-1s pros and cons (01:07:00) Outro   For more information, please see the links below. Thank you for listening!   Links:   Please consider supporting us on Patreon: https://www.lowcarbmd.com/   Resources Mentioned in this Episode: Paul Thacker on the LCMD Podcast: https://lowcarbmd.com/podcast/episode-280-paul-thacker-and-kris-newby/ Jason Fung's fasting book: https://www.amazon.com/Complete-Guide-Fasting-Intermittent-Alternate-Day/dp/1628600012   Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author   Dr. Tro Kalayjian:  Website: https://www.doctortro.com/ Twitter: https://twitter.com/DoctorTro Instagram: https://www.instagram.com/doctortro/   Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.    Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://doctortro.com/community/ 

News and Updates: Disney will fully integrate Hulu into Disney+ in 2026, creating a single streaming app while still offering standalone subscriptions. Internationally, Hulu will replace the Star brand in fall 2025. Disney expects the merger to cut costs, lower churn, and boost ad sales. Hulu + Live TV will merge with Fubo under a JV but remain separate until its own Disney+ integration in 2026. The move follows Disney's $9B buyout of Comcast's Hulu stake. ESPN and Fox will launch standalone live sports streaming services on Aug. 21, with a joint $39.99/month bundle available Oct. 2, saving subscribers about $10. ESPN's $29.99 plan includes its live channels and WWE coverage, while Fox One's $19.99 plan offers Fox News, Fox Sports, FS1, FS2, and more. Warner Bros. Discovery is also developing a direct-to-consumer TNT Sports streaming product. HHS Secretary Robert F. Kennedy Jr. wants every American wearing a health tracker within four years under his “Make America Healthy Again” plan. Critics argue it's a tech industry giveaway with minimal real health impact, costly for consumers, and a distraction from weakening public health infrastructure. CGMs and wearables can help specific patients but offer little benefit to most healthy users. OpenAI launched GPT-5, calling it its “best AI yet” with better reasoning, fewer hallucinations, and stronger coding skills. It's free for all ChatGPT tiers with tier-based usage limits. However, backlash erupted as GPT-4o and other models were removed, with users complaining GPT-5 gives shorter, less personal answers and makes basic mistakes. CEO Sam Altman promised fixes, restored GPT-4o for Plus users, and plans tweaks to model-switching and “thinking mode.”

This week on We Are T1D, things get chaotic — Jack nearly loses his foot to a digger, Mike sticks a dead sensor back on during a hypo, and the lads chat about CGMs, Type 2s, and oats. From dark humour to serious takeaways, it's one of the wildest episodes yet.What you'll hear in this episode:

IQBAR is offering our special podcast listeners 20% OFF all IQBAR products, plus get FREE shipping. To get your 20% off, text VANESSA to 64000. That's VANESSA to sixty-four thousand. Message and data rates may apply. See terms for details. Today's episode is a deep-dive recap of my mind-blowing conversation with Dr. Paul Laursen — one of the world's top experts in exercise physiology, high-intensity interval training (HIIT), and fat-adapted performance. If you've ever wondered: Why you feel better fat-fueled than carb-loaded How diet actually drives fat loss more than training Why ketones might be more than a fuel — and actually a proxy for VO₂ max How to optimize your metabolic flexibility using HIIT and protein-forward nutrition …this episode will change how you see your body composition journey — especially if you've been trying to out-exercise a poor diet.

 It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: cancer reserach may lead to T1D treatment, GLP-1 oral pill moves forward, Tandem pharmacy moves, Medtronic-Abbott sensor unveield, parents of kids with T1D see income drop, Mannkind submits Afrezza for pediatrics, diabetes scholarships and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Cornell researchers have developed an implant system that can treat type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression. The system could also potentially provide long-term treatment for a range of chronic diseases. This lab has produced previous implantable devices that have proved effective in controlling blood sugar in diabetic mice, but they can only last so long. "It's the proof of concept. We really proved that oxygenation is important, and oxygenation will support high cell-density capsules," Tempelman said. "The capsules are immune protective and last for a long time without having some kind of fouling of the membrane. The body never likes it when you put a foreign substance in. So that's the engineering in the Ma Lab, to look for materials and coatings for the materials that are immune protective, but also don't invoke excess response from the body because of the material." The next step will be to implant the system in a pig model, and also test it with human stem cells. The researchers are interested in eventually trying to use the system for implanting different cell types in humans for long-term treatment of chronic diseases, according to Tempelman, who is CEO of Persista Bio Inc., a new startup she founded with Ma and Flanders that is licensing these technologies. https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html XX Mayo Clinic cancer research may be big news for T1D. After identifying a sugar molecule that cancer cells use on their surfaces to hide from the immune system, the researchers have found the same molecule may eventually help in the treatment of type 1. Cancer cells use a variety of methods to evade immune response, including coating themselves in a sugar molecule known as sialic acid. The researchers found in a preclinical model of type 1 diabetes that it's possible to dress up beta cells with the same sugar molecule, enabling the immune system to tolerate the cells. The findings show that it's possible to engineer beta cells that do not prompt an immune response   In the preclinical models, the team found that the engineered cells were 90% effective in preventing the development of type 1 diabetes. The beta cells that are typically destroyed by the immune system in type 1 diabetes were preserved.     https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-sugar-coating-cells-can-protect-those-typically-destroyed-in-type-1-diabetes/ XX A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.   The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But the GLP-1s on the market now are expensive, must be kept refrigerated and must be injected. A pill that produces similar results has the potential to become far more widely used, though it is also expected to be expensive.   Lilly said it would seek approval from the Food and Drug Administration later this year to market orforglipron for obesity and early in 2026 for diabetes. https://www.nytimes.com/2025/04/17/health/pill-glp-1-eli-lilly.html XX Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open. Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains.       https://www.medscape.com/viewarticle/diabetes-tech-use-rise-a1c-reductions-still-lag-2025a1000lc9 XX Inflammation may predict how well people with diabetes respond to depression treatment, and the effects differ dramatically between type 1 and type 2 diabetes. Diabetes and depression often appear together. Indeed, depression is more than three times more prevalent in people with type 1 diabetes (T1D) and nearly twice as prevalent in people with type 2 diabetes (T2D). When they appear together, treatment for depression can vary widely. In a new study, researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (FIDAM), and the German Center for Diabetes Research (DZD) investigated how inflammation in the body relates to improvement in depression symptoms in people with T1D and T2D. The researchers combined data from three previous German randomized clinical trials that aimed to reduce elevated depressive symptoms and diabetes distress in people with type 1 or type 2 diabetes. Diabetes distress is characterized by feelings of overwhelm, frustration, guilt and worry about diabetes management and its potential complications. A total of 332 participants with T1D and 189 with T2D who had completed both a baseline and 12-month follow-up examination were included in the present study. Measures included depression using the Center for Epidemiological Studies Depression scale (CES-D), blood tests for 76 inflammatory biomarkers, and symptoms broken down into cognitive-affective (e.g., feeling hopeless), somatic (e.g., poor sleep, fatigue), and anhedonia (loss of pleasure) clusters.   After adjusting for factors like age, body mass index (BMI), diabetes duration, cholesterol, and co-existing illnesses, the researchers found that in patients with T1D, higher baseline inflammation was linked to smaller improvements in depression. Inflammation seemed to be more connected to physical/somatic symptoms in T1D patients. In those with T2D, higher baseline inflammation was linked to greater improvements in depression. For these patients, the effect was strongest for cognitive-affective and anhedonia – so, emotional and motivational – symptoms.   The researchers weren't sure what caused the difference between T1D and T2D, but they suggest it might be due to the different forms of immune activation seen in each condition. That is, autoimmune processes in type 1 and metabolic inflammation in type 2. https://newatlas.com/health-wellbeing/inflammation-diabetes-depression-treatment/ XX Parents of children diagnosed with type 1 diabetes suffer an income drop in the years following the diagnosis. The impact is more pronounced in mothers, especially mothers of children diagnosed in preschool years. And these findings come from a European study.. not the US. Previous research has shown that parents of children with type 1 diabetes are at increased risk of stress-related symptoms and may need to reduce their working hours. "In our study, we observed reduced parental work-related incomes in the years following the child's type 1 diabetes diagnosis. The drop was larger in mothers than in fathers. Since mothers earned significantly less than fathers in absolute terms, even before the child fell ill, the relative drop in mothers was 6.6% the year following diagnosis compared to 1.5% in fathers. We further note the greatest impact on work-related incomes in mothers of children diagnosed at preschool age," says Beatrice Kennedy, physician at the Endocrine and Diabetes unit at Uppsala University Hospital and Associate Professor of Medical Epidemiology at Uppsala University, who led the study. This is a huge study, builds on data from national population and health registers and the Swedish Child Diabetes Register (Swediabkids). The study includes the parents of more than 13,000 children diagnosed with type 1 diabetes in Sweden in 1993−2014, as well as more than half a million parents in the general population who have children not diagnosed with diabetes.   The researchers observed that the maternal pension-qualifying incomes (a composite outcome including work-related income and societal benefits) initially increased after the child's diagnosis. This was attributable to mothers applying for the parental care allowance from the Swedish Social Insurance Agency. The parental care allowance was intended to compensate for disease-related loss of work-related income and contribute toward disease-specific costs.   When the research team investigated long-term effects in mothers, they found that the pension-qualifying incomes gradually decreased after eight years, and had not recovered by the end of follow-up − 17 years after the children were diagnosed. https://www.news-medical.net/news/20250811/Mothers-face-greater-financial-impact-following-childe28099s-type-1-diabetes-diagnosis.aspx XX The U.S. Department of Justice has reached a settlement with Metro Nashville Public Schools after allegations that the district violated the Americans with Disabilities Act.   The parents of a student at the Ross Early Learning Center requested that the school monitor their child's glucose monitor. Investigators found the school refused to do so, despite the child's Type 1 Diabetes diagnosis.   As part of the settlement, MNPS agreed to change its policies to allow the use of these devices, ensure trained staff can monitor them throughout the entire school day and at school activities, and improve communication with parents. https://www.wsmv.com/2025/08/12/metro-nashville-public-schools-settles-allegations-it-discriminated-against-students-with-diabetes/ XX Modular Medical has unveiled Pivot, its next-generation insulin patch pump technology aimed at simplifying diabetes care. The company announced its new pump for “almost-pumpers” at the Association of Diabetes Care & Education Specialists (“ADCES”) Conference in Phoenix, Arizona this weekend. It aims for Pivot to target adults with a user-friendly, affordable design.   Modular Medical's current pump, the MODD1, won FDA clearance nearly a year ago. It features new microfluidics technology to allow for the low-cost pumping of insulin. The system has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery.   The company announced recently that it validated its insulin pump cartridge line for human-use production in the U.S. Days later, it reported the first human use of the MODD1 pump.   Now, it has taken the next steps with the debut of a next-gen pump, set for FDA submission in October.   Modular Medical also gamifies diabetes care The company also said ADCES is the place where it will showcase the first playable level of its new Pivot pump gamified trainin module. Level Ex, a developer of medical games, develops the module.   Modular Medical said gamification offers a way to make medical training more effective and efficient while improving information retention. Given the complexity in pump uptake, the company hopes to provide an easy way to bring its technology to clinicians and patients.   The company expects to have training modules available at the same time as the pump's planned launch in 2026.   “Level One is free because diabetes mastery shouldn't come with a price tag,” Sam Glassenberg, CEO of Level Ex, said. “Modular Medical is breaking barriers too – bringing pump therapy to more people through smart, accessible design. Together, we intend to make diabetes management simpler and more inclusive.   “People learn best through play – and we believe they want to learn about insulin pumps the same way. In Level One, players aren't just mastering diabetes management through gameplay – they're asking to ‘play' with pumps: to explore how they work, understand their benefits, and build confidence before using them in real life. Our partnership with Modular Medical helps make that possible.” https://www.drugdeliverybusiness.com/modular-medical-unveils-next-gen-insulin-pump/ XX On Tuesday, 12 August 2025, Tandem Diabetes Care (NASDAQ:TNDM) presented at the Canaccord Genuity's 45th Annual Growth Conference, outlining strategic shifts and market focus. The company highlighted its plans for commercial transformation in the U.S. and expansion in international markets, alongside addressing competitive challenges and regulatory impacts. While optimistic about growth in Outside the U.S. (OUS) markets, Tandem is navigating a more competitive landscape domestically. We have entered into the pharmacy channel with Mobi only. And so as Mobi's been building up volume, we're getting experience and we're really learning and understanding what pharmacy offers to us. And the proof points have proved out the thesis I said earlier, which is it can really reduce that barrier for patients, is the out of pocket cost. And so we've decided to accelerate our strategy and where we were starting just with Mobi, we are now moving t slim supplies into the pharmacy channel, and that will kick into gear in the fourth quarter. So as people are looking at the cadence of sales for the remainder of the year with this reframing, many folks are seeing what looks like a a might be an outsized fourth quarter and and having trouble understanding those dynamics. We'll be adding the tSIM supplies to those contracts. We also have more coverage. We will have it in the coming weeks effective this year, so we will be increasing that 30% rate before the end of the year. And then, obviously, everyone's in the same cycle right now already negotiating and discussing their 2026 coverage. And so 30% is the floor.   We do expect to continue to grow that coverage in the coming years, and ultimately have a much broader access. Absolutely. It's an exciting technology that allows for us to have an infusion set that extends the wear time from three days to up to seven days. So we're able to use that as part of an independent infusion set, which would then be used with the t slim and with the mobi pump today. But we're also using that same technology as part of the site that's used for mobi when you use it with a tubeless cartridge. So next year, we will launch Mobi in a patch configuration.   It uses the same pump that's available today, but by using a modified cartridge, you're able to wear it as a patch pump. So one of the things we announced on the call is that we're using this extended wear technology as part of that site. So what it allows you to do is to change the portion that you wear in your skin separate from the timing of when you change the insulin cartridge. So it allows for that extended wear time, reduction of burden to the patient, which is especially important for higher volume insulin users as we expand into type two. So from here, we will launch the extended wear site next year along with we'll do a separate regulatory filing for the cartridge portion for Mobi that includes this extended wear technology as a predicate device. So that's another filing that we'll need to do, but we have the clearance today for the independent infusion set, but we'll file another five ten k for use of the extended wear technology as part of the tubeless Mobi feature. https://za.investing.com/news/transcripts/tandem-diabetes-at-canaccord-conference-strategic-shifts-and-market-focus-93CH-3834464 XX MannKind today announced a significant regulatory submission and a large financing agreement with Blackstone. The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said.   First, the Danbury, Connecticut-based company announced that it submitted a supplemental Biologics License Application (sBLA) for Afrezza, its inhaled insulin product, in the pediatric population.   MannKind Director of Medical and Scientific Engagement Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, told Drug Delivery Business News at ADA 2025 that a submission was on the way for children and adolescents aged 4-17 years old. Further data shared at ADA found Afrezza both safe and effective in that age range.   Afrezza is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion of the insulin cartridge, then the user closes it. The only other component is a mouthpiece for the sake of cleanliness. Then, the inhalation takes just two seconds. It requires no electronics or extra components.   The company expects a review acceptance decision early in the fourth quarter of 2025.   “The submission of our supplemental Biologics License Application (sBLA) for Afrezza in pediatric patients is a meaningful milestone for MannKind and people living with diabetes,” said Michael Castagna, CEO of MannKind Corporation.   Additional funding provides a significant boost for MannKind MannKind also announced a strategic financing agreement with funds managed by Blackstone worth up to $500 million. The financing provides MannKind with non-dilutive capital to advance its short- and long-term growth strategies.   This senior secured credit facility includes a $75 million initial term loan funded at closing. It then has a $125 million delayed draw term loan available for the next 24 months. Finally, it features an additional $300 million uncommitted delayed draw term loan available at the mutual consent of MannKind and Blackstone.   The facility bears interest at a calculated SOFR variable rate plus 4.75% and matures in August 2030.   “This strategic financing significantly increases our operating flexibility and provides us substantial access to non-dilutive capital on favorable terms, complementing our strong cash position,” said Castagna. “The funding will support the expansion of our commercial team in preparation for the anticipated launch of the pediatric indication for Afrezza, if approved, continued pipeline advancement, potential business development opportunities, and general corporate purposes. Partnering with the Blackstone team on this transaction positions us to accelerate our next phase of growth and innovation.” https://www.drugdeliverybusiness.com/mannkind-fda-submission-pediatrics-500m-blackstone/ XX   Medtronic MiniMed Abbott Instinct Sensor [Image from Medtronic Diabetes on LinkedIn] The Medtronic Diabetes business today took to social media to share an early preview of a new integrated Abbott sensor for its insulin delivery systems. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – said in the post that the new sensor specifically designed for its own systems is called “Instinct.”   “Get a sneak peek at what's coming next: the Instinct sensor,” the business unit's account wrote. “Made by Abbott, the Instinct sensor is designed exclusively for MiniMed systems. We'll share more details about the Instinct sensor when it's commercially available.”   The sensor, built on the Abbott FreeStyle Libre platform, reflects “the power of the partnership,” Abbott EVP, Diabetes Care, Chris Scoggins, told Drug Delivery Business News earlier this year.   Medtronic and Abbott — two of the largest diabetes tech companies in the world — announced a year ago that they entered into a global partnership pairing Abbott continuous glucose monitors (CGMs) with Medtronic insulin delivery systems.   The partnership aims to collaborate on a system based on Abbott's FreeStyle Libre CGMs with Medtronic's automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as the InPen system.   Read more about Medtronic, Abbott and the rest of the diabetes tech industry in our free Diabetes Technology Special Report. Medtronic's systems previously used its own CGMs, such as the Guardian 4 and the Simplera platform, and the company intends to continue using those systems as part of a comprehensive CGM portfolio. Under the companies' agreement, the systems would be sold exclusively by Medtronic — including the Abbott CGM.   The companies brought the partnership a step further in April when Medtronic announced the submission of an interoperable pump with the Abbott sensor technology to the FDA. They plan to share more details following the expected FDA clearance, which remains pending.   Management also recently emphasized the multi-year nature of the partnership, meaning Medtronic could pair current and future pumps with other Abbott sensors in the future. That could hint at integration with the company's future dual glucose-ketone monitor, as a number of pump makers have already announced collaborations to pair their systems with the sensor once it hits the market. https://www.drugdeliverybusiness.com/medtronic-diabetes-previews-abbott-sensor-minimed/ XX Governor Glenn Youngkin joined Civica officials at the company's Petersburg manufacturing facility to announce a $3 million grant from the Commonwealth of Virginia to accelerate Civica's efforts to develop and produce affordable insulin for Americans living with diabetes.   CivicaRx Logo   "We are proud to partner with Civica in their mission to make essential medicines more accessible," said Governor Youngkin. "This investment reflects our belief in the power of public-private collaboration to improve lives and strengthen communities."   These funds will support the production of insulin aspart, a rapid-acting human insulin analog used to regulate blood sugar in adults and children with diabetes. Civica plans to produce both rapid- and long-acting insulins at its state-of-the-art manufacturing facility in Petersburg, Va., where the company now employs more than 200 skilled workers.1 Over 8 million people living with diabetes need rapid-acting and/or long-acting insulin.   The Governor also announced that he had officially proclaimed August 7 – 14 2025 'Life Sciences Week' demonstrating the Commonwealth's commitment to "accelerating the advancement of the life sciences through public-private partnerships, STEM education, workforce development, and sustained investment in research and development."   "We are grateful for the Commonwealth's support," said Ned McCoy, Civica's President and CEO. "This funding will help us move closer toward our goal of ensuring that no one has to choose between insulin and other basic needs."   Civica and Virginia officials were joined by Lynn Starr, Chief Global Advocacy Officer of Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization.   "More than one million American adults live with type 1 diabetes, and many still, sadly, ration their insulin, due to the prohibitively high cost of this necessary medication," said Starr.  "Civica's work will help to make insulin more affordable for people across the country."   Breakthrough T1D is among more than two dozen organizations and philanthropists, along with the states of Virginia and California, that have partnered with Civica to support the development of affordable insulins.   Civica's insulin initiative aims to provide patients with predictable, transparent pricing — no more than $30 per vial or $55 for a box of five pens — regardless of insurance status.   About Civica Civica is a nonprofit pharmaceutical company established to address drug shortages. It was founded by a group of U.S. health systems and philanthropies who, after more than a decade of chronic shortages, recognized that the market was not self-correcting and that a different approach is required. Civica works to deliver a safe, stable, and affordable supply of essential medicines to U.S. patients.   Media Contact: Liz Power liz.power@civicarx.org +1 860 501 3849 https://cbs4indy.com/business/press-releases/cision/20250807NY46213/governor-glenn-youngkin-announces-3-million-grant-to-support-civicas-affordable-insulin-programs/ XX If you or someone you love is living with diabetes, you already know the fight isn't just medical—it's financial, too. Between daily supplies, doctor visits, and long-term care, the cost of managing type 1 or type 2 diabetes can be overwhelming. Add college or trade school into the equation, and suddenly staying healthy competes with building a future. That's where scholarships for students with diabetes—like Beyond Scholars and others listed here—step in.   Whether you're headed to a university, a two-year college, or a hands-on trade program, these opportunities were created to ease the load.   Scholarships for students with diabetes Beyond Scholars (from Beyond Type 1): $10,000 for recently graduated high school seniors with type 1 diabetes or type 2 diabetes entering college or trade school. This is one of the largest needs-based diabetes scholarships in the United States. This year, awardees will also receive 6 months of wellness coaching through Risely Health.   Applications open: July 25, 2025 Deadline: August 29, 2025 Winners announced: October 2025 https://beyondtype1.org/beyond-scholars-diabetes-scholarships-college-trade-school/ XX Nick Jonas and Kyle Rudolph are using their platforms for a good cause.   On Tuesday, Aug. 12, the singer and the former NFL tight end (via his professional fundraising platform Alltroo) announced they're teaming up to launch a rally featuring a fan-coveted prize: a custom 2025 Volkswagen ID. Buzz electric bus that the Jonas Brothers have brought along for their 20th anniversary tour.   “Ten years ago, we hit the road with a goal to change what it means to live with diabetes. Since then, Beyond Type 1 has grown into the world's largest digital diabetes community, offering the tools, education, and peer support needed to not only survive but thrive with diabetes,” Jonas, who co-founded Beyond Type 1 (a nonprofit that advocates for those living with diabetes), says in a statement.     “We've challenged stigma, built community, provided life-saving resources, and collectively driven global innovation toward prevention and cure. This milestone is a moment to rally even more support for our mission, and partnering with Alltroo helps us do that in a powerful, engaging way.”   Related Stories Nick Jonas on Managing His Diabetes: 'The Mental and Emotional Health Aspect Is Really Important' nick jonas Nick Jonas Says He Was Diagnosed with Diabetes After Joe Told Their Parents: 'Something's Really Wrong' Joe Jonas and Nick Jonas attend the amfAR Cannes Gala 30th edition at Hotel du Cap-Eden-Roc on May 23, 2024 For Rudolph, the campaign is about "celebrating Beyond Type 1's incredible work over the past decade, and standing behind their vision of a world where everyone with diabetes — or at risk of it — has access to the knowledge, care and support needed for early diagnosis and lifelong health."   While the rally is live on Alltroo.com, fans can also scan QR codes available at all 36 Jonas Brothers concert stops to enter for a chance to win the electric bus. (A winner will be selected on November 14, which is World Diabetes Day.)   Jonas, 32, has long been open about his Type 1 diabetes diagnosis at 13 years old. "I had this kind of wrench thrown into things when I was diagnosed and it took a while to figure out how to count carbs to properly dose for insulin and what things would affect me in different ways," he previously told PEOPLE.   "When I was first diagnosed, I was sitting in the hospital and was scared to death, honestly, while I was learning about how to manage this new thing I was dealing with," Jonas recalled. "It would have been amazing to have someone to look at at that time to say, oh, this is a person living with it and they're following their dreams. They're doing what they want to do with their lives and not letting it slow them down."           https://people.com/nick-jonas-kyle-rudolph-launch-fan-rally-diabetes-awareness-11788684

 This episode is brought to you by Audible, LMNT and Cured Nutrition. In this episode of Ever Forward Radio, we sit down with Ben Azadi, author of Metabolic Freedom, to uncover the truth about metabolism and its role in energy, fat loss, and longevity. Ben shares why 93% of Americans are metabolically unhealthy, the dangers of the “glucose rollercoaster,” and why snacking may be accelerating aging. You'll learn the importance of fasting insulin testing, how muscle mass protects metabolic health, the role of stress and cortisol in stubborn fat, and simple strategies to move from metabolic “prison” to metabolic freedom. Follow Ben @thebenazadi Follow Chase @chase_chewning ----- In this episode we discuss... 00:00 – Introduction to Ben Azadi & Metabolic Freedom 03:02 – The “Glucose Rollercoaster” explained & why it matters 05:26 – Carb limits for prediabetes vs type 2 diabetes 08:41 – Fasting insulin: the real metabolic marker 10:26 – Affordable ways to improve metabolic health 11:39 – Snacking & the Hayflick limit: why grazing ages you faster 17:39 – The body's resilience vs the dangers of ignoring symptoms 19:14 – Metabolism myths: efficiency over speed 25:32 – How muscle mass prevents metabolic decline with age 29:17 – Post-meal walks & controlling insulin spikes 31:31 – Are glucose spikes really bad? The role of metabolic flexibility 33:35 – CGMs: useful tool or unnecessary gadget? 35:57 – Foundations first: food quality, sleep, stress, movement 37:48 – Stress, cortisol belly, and HRV tracking 41:18 – Cold plunging: benefits, risks, and adaptation 42:45 – Writing Metabolic Freedom: calories vs hormones & inflammation 45:48 – The power of belief: the refrigerator cart story 48:37 – What “Ever Forward” means to Ben Azadi 50:03 – Where to find Metabolic Freedom and connect with Ben ----- Episode resources: Free 30-day trial of Audible FREE variety sample pack with any purchase of LMNT 20% off Serenity Gummies with code EVERFORWARD Watch and subscribe on YouTube Learn more at BenAzadi.com

Can AI spot your health problems faster than a doctor? We all know the grind: long hours, too much stress, and that feeling of burnout that never seems to go away. Traditional medicine often just slaps a Band-Aid on the symptoms, leaving the root cause unaddressed. But what if there's a better way to get to the bottom of what's really going on with your body? Discover how AI-powered health tracking can pinpoint hidden issues like low testosterone and stress-induced glucose crashes. Learn how to use your own biometric data to have more productive conversations with your doctor. And find out what simple lifestyle changes can make a massive difference in your mental and physical well-being. Listen now to learn how to turn your health data into actionable insights. Topics Discussed: - AI and Testosterone: Garrett shares his personal journey of using an AI chat to pinpoint a potential diagnosis of hypogonadism due to head injuries, which was later confirmed by blood tests. - The Problem with Doctors: A major frustration is the lack of time doctors have to truly sift through a patient's complex history to find the root cause of issues like chronic stress or low energy. - Biohacking with Wearables: Wearable tech and continuous glucose monitors (CGMs) can reveal surprising correlations between emotional stress and physical biomarkers, like a fight with a partner causing a blood sugar spike. - The Biopsychosocial Model: The conversation highlights how physical health and mental health are inextricably linked and that physical issues can often manifest as psychological symptoms and vice versa. - Trusting Your Data: The hosts discuss the balance between trusting the data from wearables and listening to your own body's intuition, noting that the data isn't foolproof. - Quick Fixes vs. Root Causes: The discussion touches on how Western medicine often focuses on treating symptoms with quick fixes like medication, rather than addressing the underlying lifestyle factors. - The Power of Feedback Loops: Using AI and wearables creates a tighter feedback loop, allowing people to experiment with lifestyle changes and see the results faster, which helps maintain motivation. - Burnout as a Lifestyle Choice: Burnout is framed not just as a workplace issue but as a lifestyle problem driven by priorities that don't include recovery. - Behavioral Change is Hard: The hosts acknowledge that knowing what to do isn't the same as doing it, and that current behaviors often serve a purpose, even if they're unhealthy. - Data Privacy Concerns: Garrett acknowledges the risk of sharing personal health data with AI but weighs the benefit of gaining health insights against the potential for data leaks. Guest Website Gnosis Therapy (Garrett Wood's practice)  Garrett on LinkedIn Resource List: Home Readiness Assessment Books: The Biological Mind by Dr. Alan Jeffers  Wearable Tech: Oura Ring Continuous Glucose Monitors (CGM) 

Our kidneys filter out waste while retaining substances the body needs, such as electrolytes. Kidney health, which can be assessed with blood and urine biomarker tests, is paramount to overall health. Yet lifestyle, such as the Western diet and other factors, can damage the kidneys, leading to either a slow progression of issues or acute injury. Dr. Rick Johnson and Mike Haney discuss the role of the kidneys, what lifestyle factors affect kidney health, ways to support the kidneys, and what your biomarker results tell you about the function of these crucial organs.Sign Up to Get Your Free Ultimate Guide to Glucose: https://levels.link/wnl

Dr. Tro Kalayjian is a board-certified physician in Internal Medicine and Obesity Medicine, and the founder of Toward Health, a virtual metabolic health clinic helping people break free from food addiction and chronic metabolic disease. He's also a founding member of the Society of Metabolic Health Practitioners and an international speaker on metabolic psychiatry, obesity, and nutrition science. But what makes Dr. Tro's work truly powerful is that it's personal. He grew up in a household affected by obesity and struggled with his own weight into adulthood, reaching over 350 pounds. After years of frustration with traditional medical advice, he took a deep dive into the research and completely transformed his health—losing over 150 pounds and sustaining that loss for more than a decade. His clinic's latest research, published in Frontiers in Psychiatry, shows how combining low-carb nutrition with real-time support, psychological care, and metabolic monitoring can significantly reduce food addiction and binge eating symptoms—offering hope for those who haven't found relief in diets or medications alone. Dr. Tro is passionate about helping others find food freedom, and today he's here to share the science, the struggle, and the solutions that actually work. Research Highlights: Published in Frontiers in Psychiatry (2025): 43 lbs average weight loss ~40–50% improvement in food addiction and binge eating symptoms Outcomes comparable to medications (e.g. amphetamines, GLP-1s) — but without long-term side effects Case series (220 people) on keto for binge eating showed significant improvements, challenging the old myth that "restrictive diets worsen eating disorders"

Episode #217 In this episode, Terri and Heather dive into the foundational framework behind lasting fasting success—what they call “The Three-Legged Stool.” They unpack the three essential components: 1️⃣ The Fasting Dial – finding the right rhythm for your body 2️⃣ The Nutrition Dial – nourishing in a way that supports your goals 3️⃣ The Support Dial – staying consistent through accountability and connection Terri and Heather explain why all three dials must be in balance—because when one leg is missing, the whole stool wobbles. If you're struggling to stick with fasting, lose weight, or feel your best, this conversation will help you reconnect with the core principles that create sustainable, long-term success. ✨ Think of this as your reset to realign and thrive—no extremes, just solid strategy.  

How can we prevent our older adults with prediabetes from developing diabetes?  Susan is a board certified health and wellness coach.  She is a certified with the CDC diabetes prevention program and owner of Weighting4You.  She will walk us through the use of continuous glucose monitors (CGMs) to assist with lowering HgbA1c, counseling tips for patients on GLP-1 RAs, and more.  I hope you enjoy our conversation.   The Geriatric Pharmacy Focus podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Connect with Tamara here:  www.linkedin.com/in/tamara-ruggles-491882251 www.thedeprescribingclinic.com Connect with Susan here:linkedin.com/in/susanward https://weighting4you.com/

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: FDA approves the first fast-acting biosimilar insulin in the US, Tandem issues warning, DOJ stands up for remote monitoring in schools, GLP1 use protects against dementia, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX We've got the first and only biosimilar FDA approved and moving to market. Kirsty – insulin aspart, which is a biosimilar to Novolog will be available as a single-patient-use prefilled pen for subcutaneous use and a multiple-dose vial for subcutaneous and intravenous use. KIRSTY has been available in Europe and Canada since 2022. This same company makes Semglee, the first biosimilar for long acting? Sales of Insulin Aspart in the United States were approximately $1.9 billion in 2024, according to IQVIA. https://www.globenewswire.com/news-release/2025/07/15/3115973/0/en/Biocon-Biologics-Expands-Diabetes-Portfolio-with-FDA-Approval-of-Kirsty-the-First-and-Only-Interchangeable-Rapid-Acting-Insulin-Aspart-in-the-United-States.html XX Tandem Diabetes Care (Nasdaq:TNDM) has issued an urgent medical device correction for some t:slim X2 automated insulin pumps. In a July 22 notice, the San Diego-based company warned of pumps that may exhibit a higher rate of speaker failure. During normal use, the insulin pump software monitors current flowing through the speaker during use. Measurements that fall within a pre-determined range indicate a functioning speaker. Meanwhile, measurements falling outside the range indicate a speaker failure.   When the measurements land outside the expected range, the system declares a malfunction, referred to as “Malfunction 16.” If the pump declares this malfunction, insulin delivery will stop and the pump will no longer be operational. Malfunction 16 terminates communication between the pump and continuous glucose monitor (CGM), as well as the t:slim mobile app.   If not addressed, the issue can lead to hyperglycemia, which can result in hospitalization or medical intervention. The company reports 700 adverse events and 59 reported injuries to date, with no reports of death.   Tandem identified that certain speaker versions have a higher rate of Malfunction 16 events due to a wiring issue within the speaker. Users can continue using their pump but with added precautions because Malfunction 16 can occur at any time. They should use the t:slim mobile app with push notifications turned on so the app alerts them if the malfunction occurs, the company said.   Additionally, Tandem intends to release a software update aimed at enhancing the early detection of speaker failure. The update also introduces persistent vibration alarms to help reduce potential safety risk. Tandem plans to notify affected pump users when it makes the update available. https://www.drugdeliverybusiness.com/tandem-warns-insulin-pump-speaker-malfunction/ XX BIG WIN! The DOJ protects T1D rights again! The US Attorney's office for the Western District of Washington State reached a settlement with a public school district that once again confirms remotely monitoring students' CGMs is a reasonable accommodation that schools must provide to comply with the Americans with Disabilities Act. If its true for one state its true for all states under federal law! If your local schools still refuse to remotely monitor CGMs of their students, provide them with this letter to compel them to FOLLOWT1Ds and FOLLOW Federal Laws. If they still refuse contact us! https://followt1ds.org/ XX new study finds people taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin users. Past studies show that people who have type 2 diabetes — a chronic condition where the body does not use its insulin properly — are at a higher risk of developing dementia. The study found that when comparing the neuroprotective abilities of two diabetes medications — metformin and glucagon-like peptide-1 receptor agonists (GLP-1 agonists) — participants taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin.   https://www.medicalnewstoday.com/articles/glp-1s-may-offer-better-dementia-protection-than-metformin XX Front office changes coming to Dexcom.  CEO Kevin Sayer will step down  & give the reins to current Chief Operating Officer Jake Leach. Scheduled for January 1, 2026, Leach will also join Dexcom's board of directors where Sayer will remain  executive chairman. One of our frequent guests here.. Leach has worked at Dexcom for 21 years. He served as chief technology officer from 2018 to 2022 before he was named COO in late 2022. He was given the title of president in May. https://www.medtechdive.com/news/dexcom-ceo-change-kevin-sayer-jake-leach/756382/ XX A major international study has revealed that many children and young adults in Sub-Saharan Africa who are diagnosed with type 1 diabetes (T1D) may actually have a different, non-immune-based form of the condition. Unlike the traditional autoimmune version of T1D, this form appears to develop without the immune system attacking the insulin-producing cells. This finding could significantly reshape how diabetes is diagnosed and treated across the region, potentially leading to more precise care and better health outcomes. The researchers found that many young people in Sub-Saharan Africa diagnosed with T1D often don't have the usual markers in their blood (called islet autoantibodies) typically seen in people with T1D in other parts of the world. Specifically, 65% of participants with T1D in this region did not have islet autoantibodies. When the researchers compared this data to studies in the U.S., they found a smaller but significant proportion (15%) of Black participants diagnosed with T1D had a similar form of diabetes found in Sub-Saharan Africa – characterized by negative autoantibodies and a low T1D genetic risk score.   However, white Americans with T1D showed the typical autoimmune pattern, even if they didn't have detectable autoantibodies, their genetics still pointed to autoimmune diabetes.   “The identification of this T1D diabetes subtype in Sub-Saharan African populations and among individuals of African ancestry in the U.S. suggests a potential ancestral or genetic link,” Dabelea notes. “These findings highlight the need to consider alternative etiologies in this group and a deeper understanding of the underlying mechanisms may provide important insights for future prevention and treatment strategies.”     https://scitechdaily.com/new-diabetes-subtype-discovered-in-africa-challenges-global-assumptions/   XX Formal recognition for the specialty of Diabetology.   Diabetology is the specialty focused on the full continuum of diabetes care — encompassing diagnosis, treatment, prevention, technology integration, education, and cardiometabolic management. While it intersects with endocrinology, primary care, and public health, diabetology is uniquely defined by its depth and focus on diabetes alone.       The American College of Diabetology (ACD) is the national professional organization representing clinicians who specialize in diabetes care. ACD advances clinical excellence and education to improve the lives of those affected by diabetes. https://www.businesswire.com/news/home/20250725766248/en/American-College-of-Diabetology-Announces-Formal-Taxonomy-Classification-for-Diabetology   XX Tidepool announces cloud-to-cloud integration with Abbott's FreeStyle Libre portfolio. From the release: This integration allows people living with diabetes using the FreeStyle Libre portfolio to connect their data to their Tidepool account seamlessly. For healthcare providers, this means more comprehensive insights and streamlined workflows, with FreeStyle Libre systems data flowing continuously into the Tidepool Data Platform. https://www.tidepool.org/blog/abbott-freestyle-libre-integration-launched XX Stelo dexom ai food XX With high drug prices remaining an ongoing concern for U.S. politicians, Roche is considering following in the footsteps of some of its peers with a direct-to-consumer (DTC) model to cut out the middlemen.     About 50% of the money spent on drugs in the U.S. healthcare system goes straight to PBMs instead of the companies that create the medicines, Roche CEO Thomas Schinecker called out in a press conference on Thursday.   Bringing the drugs directly to the consumer could be a solution to positively impact pricing for patients “without destroying innovation,” Schinecker added on a separate Thursday call with investors, noting that the company has discussed the matter with the U.S. government and its Department of Health and Human Services. The pricing talks come after President Donald Trump inked a “Most Favored Nation” executive order in May, aiming to tie U.S. drug prices to lower prices in other developed nations. The plan was quickly called out by industry voices such as the PhRMA trade group, which labeled it a “bad deal” for U.S. patients. https://www.fiercepharma.com/pharma/roche-weighing-direct-consumer-drug-sales-ease-us-drug-pricing-woes-cut-out-pbms-ceo-says XX SAB BIO secures substantial $175M financing to advance T1D therapy with impressive investor lineup and extended cash runway until 2028. Most critically, this financing fully funds the pivotal Phase 2b SAFEGUARD study evaluating SAB-142 for delaying progression of autoimmune Type 1 diabetes in newly diagnosed patients. By extending the cash runway into mid-2028, SAB has effectively eliminated near-term financing risk and provided clear visibility through this crucial clinical trial and potential commercialization preparation. Participation from strategic investor Sanofi, along with new investors RA Capital Management, Commodore Capital, Vivo Capital, Blackstone Multi-Asset Investing, Spruce Street Capital, Forge Life Science Partners and Woodline Partners LP, and existing investors Sessa Capital, the T1D Fund, and ATW Partners         https://www.stocktitan.net/news/SABS/sab-bio-announces-oversubscribed-175-million-private-fwsf2t91ek4z.html   XX In a landmark 14-year study, researchers have found that artificially sweetened drinks raise the risk of developing type 2 diabetes by more than a third, significantly higher than those loaded with sugar. It challenges the long-standing perception of diet drinks being a healthier alternative and suggests they may carry metabolic risks of their own. In the first longitudinal study of its kind, led by Monash University, researchers tracked 36,608 participants over an average period of 13.9 years to assess how both sugar-sweetened beverages (SSBs) and artificially sweetened beverages (ASBs) impacted health outcomes. The self-reported health data, from the Melbourne Collaborative Cohort Study, was drawn from participants aged 40 to 69 years at the time of recruitment.   What they found was that drinking just one can of artificially sweetened soda increased the risk of developing type 2 diabetes by 38%, compared to people who didn't consume these drinks at all. For those consuming the same amount of sugary drinks, the risk was 23% higher. This suggests there's more than obesity at play. The researchers believe this result is due to an independent metabolic effect, possibly gut microbiome disruption or a change in glucose metabolism.   While the study didn't identify which artificial sweeteners were at play,   Evidence suggests that artificial sweeteners can alter the composition and function of gut bacteria, leading to glucose intolerance – a precursor to type 2 diabetes. And that some sweeteners may trigger insulin release, desensitize metabolic responses over time, or confuse the body's glucose regulation system – even without actual sugar in the picture.   Another hypothesis is that regular exposure to the kind of intense sweetness that artificial products deliver may condition the body to anticipate sugar calories that never come, affecting appetite regulation, insulin sensitivity and broader metabolic pathways. However, the authors suggest that how sweeteners affect the gut microbiota and glucose regulation are the most likely drivers of increased diabetes risk.   https://newatlas.com/diet-nutrition/one-drink-diabetes-risk/ XX After months of deliberation, information gathering and public testimony, a state board unanimously agreed Monday that two common medications for type-2 diabetes and other conditions appear to pose an affordability challenge to the state and Marylanders.   The state Prescription Drug Affordability Board approved two resolutions saying that prescription drugs Jardiance and Farxiga likely pose an “an affordability challenge for the state health care system” and the state should look for ways to bring down those costs.   Health care advocates call the long-awaited resolution an “important first step” in the process in bringing down prescription costs for those on the state's health plan.       That milestone has been years in the making. Created in 2019 by the General Assembly, the Prescription Drug Affordability Board was slow to launch due in part to a veto from former Gov. Larry Hogan (R) amid pandemic-induced economic uncertainty in 2020 that delayed the board's formation. The board also cited out-of-pocket costs for consumers and state and local spending on those drugs as indicators that there may be an affordability challenge.   The board will now look at options to address the potential affordability challenge, which could include setting an upper payment limit on those drugs. But it's not clear when the state will see cost savings.   That said, some members of the health care system and the pharmaceutical industry say that policies such as upper payment limits could weaken access to life-saving drugs. Others say that the board has not engaged enough viewpoints from the health care industry. https://marylandmatters.org/2025/07/29/state-board-determines-two-type-2-diabetes-drugs-may-be-unaffordable/   XX One year after it was revealed that Chrissy Teigen and John Legend's son, Miles, was diagnosed with type 1 diabetes, Teigen is revealing how she's making her son feel more included. Teigen first opened up about her 7-year-old son's diagnosis after she and her two oldest kids, Miles and 9-year-old daughter Luna were at the 2024 summer Olympics cheering on Simone Biles. Teigen posted a photo of Miles and Luna holding up a sign. Also visible in the picture was the insulin pump on Miles' arm. Now, Teigen is sharing some insight into how she's making Miles more comfortable with having type 1 diabetes, including giving LeBron James' Barbie doll type 1 diabetes as well. In a video shared on Instagram, Teigen is seen taking the T1D Barbie, removing her insulin pump and gluing the pump onto LeBron James' Barbie. “Turning T1D Barbie into T1D Lebron James for my son,” Teigen captioned the video, revealing James is Miles' hero. 41 million followers https://www.yahoo.com/lifestyle/articles/chrissy-teigen-gives-lebron-james-154608782.html  

Dr. Tracy Gapin is a renowned expert in men's health optimization and longevity with over 25 years of experience as a board-certified urologist. As the founder of the Gapin Institute for Precision Medicine, Dr. Gapin leverages his extensive background to help high-performing entrepreneurs, athletes, and executives reach their peak potential through cutting-edge, data-driven health strategies. He combines lifestyle medicine, functional medicine, epigenetics, hormone therapy, and regenerative medicine to help clients significantly enhance both their well-being and performancePlease learn more about Dr. Tracy Gapin at www.GapinInstitute.comIn this enlightening episode of Mr. Biz Radio, host Ken "Mr. Biz" Wentworth welcomes Dr. Tracy Gapin. Dr. Gapin shares his inspiring journey from a busy urologist to a trailblazer in proactive health management, empowering men to reclaim their vitality and long-term wellness. The conversation explores the pressing issue of neglected men's health and emphasizes the critical need for proactive rather than reactive medical strategies. Dr. Gapin provides actionable insights on how high-performing individuals can optimize energy, focus, and drive to achieve peak performance—both personally and professionally.Key Takeaways:-Men's health should be proactive, focusing on diagnostics and preventing illness rather than reacting once it occurs.-Comprehensive blood tests and other diagnostics provide actionable insights into health and can dramatically improve energy and focus.-Quality sleep is crucial for optimizing health, as it allows the body to repair and rejuvenate itself.-Utilize wearable tech like CGMs and rings to track metrics such as heart rate variability and sleep patterns for better health outcomes.-Understand that a one-size-fits-all strategy is ineffective; health optimization should be personalized based on individual biomarkers and lifestyle choices.

Your gut microbiome affects everything from your mental health and cognitive function to your immune system and metabolic health. Gut health symptoms, such as bloating, gas, constipation, or diarrhea, could be a sign that you have low species diversity. Dr. Will Bulsiewicz and Mike Haney discuss how the gut and brain communicate, how the gut microbiome affects the gut barrier and therefore your immune system, what to eat to improve the gut microbiome, and what microbiome testing can tell you.Sign Up to Get Your Free Ultimate Guide to Glucose: https://levels.link/wnl

Description: In the third and final episode of the healthspan series, Dr. Erin Faules and Dr. Jeff Graham explore the intersection between neurodegenerative disease and metabolic dysfunction—two often-connected drivers of decline. They discuss early detection strategies, the role of genetics, and insulin resistance, and emerging clinical tools to assess and reduce long-term risk. Key Topics Covered: Distinguishing normal aging from neurodegenerative disease Early signs of cognitive decline and how to detect them The role of APOE-4 and other genes in Alzheimer's risk Metabolic dysfunction as a driver of brain aging ("Type 3 diabetes") Blood-based biomarkers: phospho-tau, NFL, CRP, fasting insulin, and more Lifestyle interventions: sleep, strength training, CGMs, circadian-aligned eating Tools like CNS Vital Signs, PET scans, and neuroquant MRIs Supplements and prescriptions: Omega-3s, creatine, berberine, GLP-1s, inositol Connecting muscle mass to glucose control and long-term healthspan

Men's health is in crisis—and Dr. Tracy Gapin, MD is here to change that. If you're struggling with low energy, poor sleep, weight gain, low libido, or simply not feeling like yourself, this episode will show you how modern tools and personalized medicine can help.Dr. Gapin, a former urologist and founder of the Gapin Institute, dives into the real causes behind the men's health epidemic. He breaks down how advanced diagnostics, hormone optimization, and precision medicine can transform your health when traditional medicine fails. You'll learn how to use genetic testing, epigenetics, wearable technology, and CGMs to uncover health “blind spots” and take control of your energy, testosterone, brain performance, and overall vitality.This episode is packed with solutions to the problems that real men face today—from declining testosterone levels to rising inflammation, hidden gut health issues, and the dangers of seed oils. You'll learn how Dr. Gapin's G1 Program helps men optimize their biology using peptides, functional medicine, and blood testing for men that go far deeper than your annual physical.If you're searching for answers, tired of Band-Aid solutions, and ready for results, Dr. Gapin offers a new paradigm: biohacking your biology, reversing aging, and unlocking true male vitality through smart data and science.To check out Dr. Tracy Gapin's MD TEDx talk, "The Men's Health Crisis", visit: https://youtu.be/io33LOfVxxo?si=n2yBcHaywCy6ww9MTo check out the YouTube (video podcast), visit: https://www.youtube.com/@drchrisloomdphdDisclaimer: Not advice. Educational purposes only. Not an endorsement for or against. Results not vetted. Views of the guests do not represent those of the host or show.  Click here to join PodMatch (the "AirBNB" of Podcasting): https://www.joinpodmatch.com/drchrisloomdphdWe couldn't do it without the support of our listeners. To help support the show:CashApp- https://cash.app/$drchrisloomdphdVenmo- https://account.venmo.com/u/Chris-Loo-4Spotify- https://podcasters.spotify.com/pod/show/christopher-loo/supportBuy Me a Coffee- https://www.buymeacoffee.com/chrisJxClick here to schedule a 1-on-1 private coaching call: https://www.drchrisloomdphd.com/book-onlineFor audiobooks, visit: https://www.audible.com/author/Christopher-H-Loo-MD-PhD/B07WFKBG1FFollow our YouTube channel: https://www.youtube.com/chL1357Follow us on Twitter: https://www.twitter.com/drchrisloomdphdFollow us on Instagram: https://www.instagram.com/thereal_drchrislooFollow the podcast on Spotify: https://open.spotify.com/show/3NkM6US7cjsiAYTBjWGdx6?si=1da9d0a17be14d18Subscribe to our Substack newsletter: https://substack.com/@drchrisloomdphd1Subscribe to our email list: https://financial-freedom-podcast-with-dr-loo.kit.com/Thank you to all of our sponsors and advertisers that help support the show!Financial Freedom for Physicians, Copyright 2025

Behind the staggering statistics on global diabetes prevalence are millions of individuals with different stories, struggles, and solutions. In this episode, we explore how diabetes affects your brain, body, and cognition, and how it can be prevented, managed, and (in many cases) reversed. We share some powerful personal stories from the clinic, bust some persistent food myths, and learn why diabetes is as much a neurological emergency as a metabolic one. Plus, we speak to three leading experts who are changing the way we treat diabetes: BRENDA DAVIS, RD: renowned dietitian and global authority on plant-based nutrition. DR. MICHELLE MCMACKEN, MD: Executive Director of Nutrition and Lifestyle Medicine at NYC Health + Hospitals, Associate Professor at NYU, and public health leader. DR. THEODORE FRIEDMAN: Professor and Chair of Internal Medicine at Charles Drew University. In this episode, we discuss: • The difference between Type 1, Type 2, and prediabetes • How diabetes can contribute to cognitive decline • The role of lipotoxicity and intramuscular fat in insulin resistance • Why “cutting carbs” isn't the full story (and how to focus on food quality) • How public health systems are evolving to make prevention accessible and equitable • The real science behind CGMs (and why glucose spikes shouldn't cause a panic) • How new drugs like Ozempic can support (but not replace) lifestyle change This is... Your Brain On Diabetes. SUPPORTED BY: NEURO World. Help your brain thrive, now and into the future: https://neuro.world/  ‘Your Brain On' is hosted by neurologists, scientists, and public health advocates Ayesha and Dean Sherzai.  ‘Your Brain On... Diabetes' • SEASON 5 • EPISODE 10 [FINALE] Season 6, coming soon! LINKS Brenda Davis' website: https://brendadavisrd.com/ Dr. McMacken at NYC Health: https://med.nyu.edu/faculty/michelle-mcmacken Dr. Theodore Friedman at CDU: https://www.cdrewu.edu/directory/friedman-md-phd-theodore/

Dr. Robert Rountree is a functional and integrative medicine physician. He received his medical degree from the University of North Carolina School of Medicine at Chapel Hill in 1980. He completed a three-year residency in family and community medicine at the Milton Hershey Medical Center in Hershey, Pennsylvania, after which he was certified by the American Board of Family Practice. He completed extensive postgraduate studies in nutritional and herbal pharmacology and has been practicing his unique combination of traditional family medicine, nutrition, and biology in mind body therapy in Boulder, Colorado, since 1983. He's also the coauthor of three books on integrative medicine.    In this episode of Conversations for Health, we tackle Bob's journey in integrative and functional medicine, and two main topics, which could easily be multiple episodes on their own – liver health and mitochondrial health. We explore the silent epidemic of metabolic-associated fat accumulation in the liver, GLP-1s, sarcopenia, and fatty liver, and the impact of glyphosate and environmental toxins on fatty liver. We also cover recommended mitochondrial support nutrients and advancements with CGMs in supporting liver and mitochondrial health. Dr. Rountree's passion for these topics is evident throughout our conversation, and his generously shared insights into nutrients will be of interest to practitioners everywhere.    I'm your host, Evelyne Lambrecht, thank you for designing a well world with us.   Episode Resources: Dr. Robert Rountree: https://www.ifm.org/educator/robert-rountree Nutrition & Supplementation in Clinical Care Conference 2026: https://ssihi.uci.edu/news-and-media/events/nutrition-supplementation-clinical-care-2026/ Referenced Study - Common weedkiller glyphosate may be linked to liver disease epidemic, study warns: https://usrtk.org/healthwire/glyphosate-linked-to-liver-disease-epidemic/ Referenced Study - Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity: https://pmc.ncbi.nlm.nih.gov/articles/PMC11786232/ Design for Health Resources: Designs for Health - https://www.designsforhealth.com/ Designs for Health Practitioner Exclusive Drug Nutrient Depletion and Interaction Checker - https://www.designsforhealth.com/drug-nutrient-interaction/ Visit the Designs for Health Research and Education Library which houses medical journals, protocols, webinars, and our blog. https://www.designsforhealth.com/research-and-education/education The Designs for Health Podcast is produced in partnership with Podfly Productions. Chapters: 00:00 Intro. 02:11 Dr. Robert Rountree is lit up about the latest research in mitochondrial health.  4:36 Dr. Rountree's professional journey all started with a book on herbs.  8:28 Key learnings as both a functional medicine educator and a family practice doctor.  11:22 Updated terms and definitions of nonalcoholic fatty liver disease, fatty liver disease, and nonalcoholic steatohepatitis.  12:20 Why is Dr. Rountree so passionate about liver health, and why should practitioners be more informed about it?  17:04 The silent epidemic of metabolically associated fat accumulation in the liver. 18:45 Dr. Rountree's take on GLP-1s, sarcopenia, and fatty liver.  24:08 Long-term solutions and nutrient dosing for combating fatty liver.  29:10 Retest guidelines after starting a patient on a new program.  31:50 The impact of glyphosate and environmental toxins on fatty liver.  36:10 Supporting the liver's ability to process toxins.  38:52 Nutrient recommendations including berberine and dosing in standardized extract.  43:44 The gut microbiome as a major contributor to liver health.  48:09 Dr. Rountree's experiences with Designs for Health's founding days.  50:02 The importance of challenging sources in research.  54:17 Top mitochondria health nutrients.  57:53 How Dr. Rountree uses NAD in his clinical practice.  59:39 Additional recommended mitochondrial support nutrients.  1:03:51 Dr. Rountree's final thoughts on mitochondrial health and CGMs.  1:10:18 Dr. Rountree's personal favorite supplements, favorite health practices, and his altered opinion on good carbs and CGMs.

Send us a textMost people say they want to live longer. Fewer stop to ask: what does “longer” actually feel like?In this episode, Dr. Kevin White joins Dr. Nicki Byrne and Dr. Matt Kaeberlein for a fast-moving, smart, and practical conversation about health span — and what it really takes to stay strong, clear, and independent as you age.The trio breaks down the four pillars of health (eat, move, sleep, connect) and how to apply them in real life. You'll hear stories from the clinic, data that matters, and the kind of takeaways you can actually use — whether you're a curious patient or a clinician trying to make sense of continuous glucose monitors, inflammatory markers, or why one of your patients still eats sardines.This is part one of a two-part conversation originally recorded for the OptiSpan Podcast, hosted by Dr. Kaeberlein. Stay tuned for part two, where they dig into blood work, hormones, LP(a), genetic testing, and the future of personalized longevity medicine.

Have you ever felt like you were doing everything right—eating better, trying to fast, doing the workouts—and yet your energy still crashes, your brain feels foggy, or your sleep just won't improve?In this powerful conversation with bestselling author and health educator Ben Azadi, we explore what it really means to get your body back on your side. It's not through more control or more willpower—it's through listening, pausing and realigning with what your body is already trying to tell you.Ben's message is one I know so many of us need to hear right now: your body isn't broken. It's wise. And when you remove the interference (stress, disconnection, overdoing) it remembers how to heal.Inside the episode, we talk about:•Why the nervous system is the starting point for metabolic health•How Ben recovered from burnout and a panic attack in the middle of his book launch•What fasting looks like when it's in tune with your hormones (especially during perimenopause)•The surprising connection between cortisol, glucose spikes, and weight plateaus•How to use tools like HRV, CGMs, and body cues to actually listen to your stress response•Why joy, play, and oxytocin are just as important as nutrition when it comes to healingYou'll also hear Ben share his personal health rock-bottom and the mindset shift that helped him rebuild his body and come back home to himself. This one is about so much more than fasting.Resources:•Metabolic Freedom by Ben Azadi: https://amzn.to/41lWpAZ•Learn more about Ben:https://www.benazadi.com•Follow Ben on Instagram:@‌thebenazadi

In this special episode for National Diabetes Week, we're joined by dietitian, diabetes educator and self-proclaimed tech nerd, Amy Rush. With over a decade of experience, Amy shares how dietitians can confidently navigate the ever-changing world of diabetes technology to deliver more personalised care. In the episode, we discuss: The evolution of diabetes tech (CGMs, insulin pumps and beyond) Using CGM data to tailor nutrition advice Supporting behaviour change and avoiding tech overwhelm Access, equity and future trends in diabetes care Hosted by Brooke Delfino Click here for the shownotes The content, products and/or services referred to in this podcast are intended for Health Care Professionals only and are not, and are not intended to be, medical advice, which should be tailored to your individual circumstances. The content is for your information only, and we advise that you exercise your own judgement before deciding to use the information provided. Professional medical advice should be obtained before taking action. The reference to particular products and/or services in this episode does not constitute any form of endorsement. Please see here for terms and conditions.

The pancreas is a complex organ, but some key biomarkers can assess its health. The pancreas is both an exocrine organ (meaning it produces enzymes) and an exocrine organ (meaning it secretes hormones). It's a key component of your metabolic health and therefore your overall health. Dr. Robert Lustig and Mike Haney discuss key pancreatic blood work to get checked, the differences between diabetes types and what causes them, what insulin resistance is, how to restore mitochondrial function through diet and lifestyle changes, and more.Get a Free Guide to Understanding Your Lab Results: ⁠⁠https://levels.link/wnl⁠⁠Levels helps you see how food affects your health, empowering you with the tools needed to achieve health goals and improve healthspan. Levels Members gain access to the Levels app and continuous glucose monitors (CGMs), providing real-time feedback on how diet and lifestyle choices impact your metabolic health.Look for new shows every month on A Whole New Level, where we have in-depth conversations with thought leaders about metabolic health.

Curious about how long to wear a CGM, or if you even need one? In this episode, Jess walks through who benefits most from continuous glucose monitoring, how long to wear one to actually learn something, and what to do with all that data. You'll hear stories from clients who used their CGMs to connect the dots between their habits and blood sugar trends, and tips for when to pause if the tracking becomes too much.If you're living with diabetes or prediabetes and want personalized support from a Registered Dietitian Nutritionist covered by insurance, visit diabetesdigital.co to connect with our culturally aware and weight-inclusive team. And if you love the show, don't forget to rate and review us on iTunes or Spotify—it makes a huge difference! For additional resources and show notes, head to diabetesdigital.co/podcast.

This week on Diabetes Connections, Tandem Diabetes made some big announcements at the recent ADA Conference – we're going behind the headlines and asking your questions about Control IQ updates, extended wear infusion sets, what's happening with their patch pumps, and a lot more. I'm talking to Ben Mar the Director of Product marketing. We also getting into their expanded partnership with Abbott – in additional to the Libre 3 plus, they're one of the pump companies that has signed on for the future glucose/ketone sensor. A lot to get to here! This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Previous episodes with Ben Mar here Join us at an upcoming Moms' Night Out event! Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.